Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

8.470 +0.430 (+5.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
60 61 Next >
Novavax Secures FDA Emergency Authorization For Adjuvanted Covid-19 Vaccine
The U.S. Food and Drug Administration (FDA) grants emergency use authorization (EUA) to Novavax’s (NASDAQ: NVAX) lead candidate Adjuvanted (NVX-CoV2373) COVID-19 Vaccine for individuals 18 years of age... 
Via Benzinga
Novavax Sinks Despite Winning FDA Authorization For Its Covid Vaccine
The authorization comes a month after the key advisory committee meeting. 
Via Investor's Business Daily
PSNY Stock Alert: Polestar Announces 125% Sales Increase So Far in 2022
Polestar Automotive (PSNY) stock is rising higher on Wednesday following an update on the company's performance in 2022. 
Via InvestorPlace
Why Is Humanigen (HGEN) Stock Plunging 79% Today?
Humanigen (HGEN) stock is falling hard on Wednesday following the release of preliminary results from a Covid-19 clinical trial. 
Via InvestorPlace
Novavax (NVAX) Stock Pops Ahead of FDA Approval
NVAX stock has risen nearly 10% in the past five trading sessions on expectations that the FDA is going to approve its Covid-19 vaccine. 
Via InvestorPlace
More Vaccine Jabs Means Novavax Stock Is Up for Grabs
NVAX stock looks due for a bounce-back as Novavax makes strides in providing Covid-19 vaccines in the U.S. and internationally. 
Via InvestorPlace
The Good News For Moderna's Covid Shot Barely Moved Its Stock
Moderna stock reacted minimally to positive results for its updated Covid booster. 
Via Investor's Business Daily
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Novavax is hoping to launch an updated Covid booster shot. 
Via Investor's Business Daily
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. 
Via Benzinga
Which Coronavirus Stock Could Fetch Higher Returns?
This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns. 
Via InvestorPlace
Why Are Chip Stocks NVDA, AMD, INTC Down Today?
Chip stocks are sliding on Monday as some of the biggest players in the space deal with new bearish notes from analysts. 
Via InvestorPlace
What Is Going on With Novavax (NVAX) Stock Today?
NVAX stock is down more than 8% today even after a surprise announcement of a vaccine deal with the U.S. government. 
Via InvestorPlace
US Government Signs COVID-19 Vaccine Pact With Novavax, With FDA Decision Still Pending
Novavax Inc (NASDAQ: NVAX) has announced an agreement with the U.S. 
Via Benzinga
Novavax, Moderna, BioNTech Surge To 3-Month High As Omicron Boosters Loom
Moderna and BioNTech also surged to a three-month high Friday. 
Via Investor's Business Daily
Stocks Ready For A Bounce
The past few days have been volatile, but, stocks look ready for a bounce. Since the last CPI report, even energy stocks have fallen, pretty sharply in fact. 
Via Talk Markets
Is Novavax Stock A Buy After Omicron Results Impress Two FDA Experts?
The FDA is reviewing additional manufacturing data before making a decision. 
Via Investor's Business Daily
Novavax Gets Expanded Authorization From European Commission For COVID-19 Vaccine
The European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Novavax’s (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for... 
Via Benzinga
Why Is Novavax (NVAX) Stock Rallying Today?
Novavax (NVAX) stock is taking off on Tuesday after the vaccine company got approval for the expanded use of its Covid-19 vaccine in Europe. 
Via InvestorPlace
Why Is Novavax (NVAX) Stock Up 10% Today?
Interest around the potential for another Covid-19 surge this winter, as well as vaccine efficacy, has NVAX stock soaring today. 
Via InvestorPlace
Stock Market Rally Under Pressure; Micron, GM, Nike, RH Warn: Weekly Review
The major indexes sold off sharply. Micron and GM warned on earnings. 
Via Investor's Business Daily
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
The request is a boon for BioNTech and Moderna, both of which are facing a sales cliff. 
Via Investor's Business Daily
Highest Increases in Short Interest
A look at the 20 Russell 1000 stocks that have seen the largest increases in short interest as a percentage of float (SIPF) on a year-to-date basis. 
Via Talk Markets
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,... 
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax. 
Via InvestorPlace
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
As COVID-19 continues to mutate and form new variants, the FDA is calling on the major vaccine manufacturers to create a new composition of the vaccine for adults. 
Via Benzinga
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
A panel of experts will decide whether to recommend omicron-specific boosters. 
Via Investor's Business Daily
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Why Novavax Stock Is Up 11% Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Thursday after the company announced that its COVID-19 vaccine was recommended for an expanded conditional marketing authorization in the European... 
Via Benzinga
Airline Stocks Fall as American, United Continue to Cut Flights
Airline stocks are slipping on Thursday as companies are continuing to cut flights amid pilot shortages and other problems. 
Via InvestorPlace
Short Squeeze Hopes Take Weber (WEBR) Stock 13% Higher
Weber (WEBR) stock is on the move Thursday as retail traders push for a short squeeze of the American grill company's shares. 
Via InvestorPlace
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.